During the past 6 years, clinical trials employing alpha-interferon (alpha-IFN) in hairy cell leukemia (HCL) have shown dramatic improvement in the management of this disease. Complete remissions (CR), however, are relatively rare (10-15%) and a minority of patients (10-25%) do not respond adequately to alpha-IFN. The possibility that the poor response to alpha-IFN treatment could be related to a peculiar immunological phenotype of the hairy cell (HC) was investigated in this study. The results demonstrated that, in the majority of patients who failed to respond to alpha-IFN, HC showed an immunological phenotype characterized by positivity with the CD5 monoclonal antibody which is usually absent on HC and characteristically expressed on B-chronic lymphocytic leukemia cells. In fact, among the 10 HCL patients who presented with this phenotype, only 5 partial remissions (PR) and 5 minor responses (MR) were achieved, as opposed to the 3 complete remissions (CR), 19 PR and 3 MR observed in the 25 CD5-negative patients. The possibility that a more extensive immunological analysis of HCL patients at diagnosis may be predictive of the response to IFN treatment is postulated.
Scheda prodotto non validato
Scheda prodotto in fase di analisi da parte dello staff di validazione
|Titolo:||Relationship between immunological response to alpha-IFN treatment in 35 patients with hairy cell leukemia.|
|Citazione:||Lauria, F., Zinzani, P.l., Raspadori, D., Foa, R., Buzzi, M., Gugliotta, L., et al. (1990). Relationship between immunological response to alpha-IFN treatment in 35 patients with hairy cell leukemia. EUROPEAN JOURNAL OF HAEMATOLOGY, 45 Suppl 52, 3-6.|
|Appare nelle tipologie:||1.1 Articolo in rivista|
File in questo prodotto: